Bacthera Denmark A/S
Desconocido
NATPRIME: Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers
Bacthera Denmark A/S
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2023-DN-01
Delivery of Nucleic Acid Therapeutics to desired organs has become the current challenge of biotechnological applications. Advancements on t...
2024-07-10 - 2028-09-30 | Financiado
2024-07-10 - 2028-09-30 | Financiado
B-ACTIVE: Training of young scientists in the Biological regulation of the chemokine network to improve treatm...
Bacthera Denmark A/S
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-DN-01
A number of pharmaceuticals targeting cytokine/chemokine storms in lungs are in development due to an urgent new unmet medical need strength...
2023-07-05 - 2027-12-31 | Financiado
2023-07-05 - 2027-12-31 | Financiado
* No se disponen de datos de la empresa actual.